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ABSTRACT 
 
The aim of this study is to synthesize novel benzothiazolyl-amide derivatives and investigate their 
antimicrobial  activities.  N-(Benzothiazol-2-yl)-2-(4H-[1,2,4]triazol-3-ylsulfanyl)  acetamide  deriva-
tives (3a-j) were prepared by the reaction of N-(benzothiazol-2-yl)-2-chloroacetamides (1a-e) with 
appropriate 4H-[1,2,4]triazol-2-thione (2a-b). The chemical structures of the compounds were eluci-
dated by elemental analyses, IR, 
1H-NMR, 
13C-NMR and FAB
+-MS spectral data. Their antimicrobial 
activities against Escherichia coli (NRRL B-3008), Staphylococcus aureus (ATCC 6538), Pseudomo-
nas aeruginosa (ATCC 27853), Proteus vulgaris (NRRL B-123), Salmonella typhimurium (ATCC 
13311),  Methicillin-resistant  Staphylococcus  aureus  (MRSA)  (clinic  isolate),  Candida  albicans 
(NRRL Y-12983) and Candida parapsilosis (NRRL Y-12696)  were investigated. The results showed 
that all of the tested compounds were inactive against the test organisms. 
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BAZI N-(BENZOTİYAZOL-2-İL)-2-(4H-[1,2,4]TRİAZOL-3-
İLSÜLFANİL)ASETAMİDLERİN SENTEZİ VE BUNLARIN ANTİMİKROBİYAL 
AKTİVİTELERİ 
 
ÖZ 
 
Bu çalışmanın amacı, yeni benzotiyazolil-amid türevlerini sentezlemek ve bunların antimikrobiyal 
aktivitelerini  araştırmaktır.  N-(benzotiyazol-2-il)-2-kloroasetamidler  ile  uygun  4H-[1,2,4]triazol-2-
tiyonların  reaksiyona  sokulmasıyla  N-(Benzotiyazol-2-il)-2-(4H-[1,2,4]triazol-3-ilsülfanil)  asetamid 
türevleri hazırlanmıştır. Sentezlenen bileşiklerin kimyasal yapıları elemental analiz, IR, 
1H-NMR, 
13C-
NMR  ve  FAB
+-MS  spektral  verileri  ile  aydınlatılmıştır.  Bunların  antimikrobiyal  aktiviteleri  Es-
cherichia  coli  (NRRL  B-3008),  Staphylococcus  aureus  (ATCC  6538),  Pseudomonas  aeruginosa 
(ATCC 27853), Proteus vulgaris (NRRL B-123), Salmonella typhimurium (ATCC 13311), Methicil-
lin-resistant Staphylococcus aureus (MRSA) (clinic isolate), Candida albicans (NRRL Y-12983) ve 
Candida parapsilosis’e (NRRL Y-12696) karşı araştırılmıştır. Sonuçlar test edilen tüm bileşiklerin, 
test organizmalarına karşı inaktif olduğunu gösterdi. 
 
 
Anahtar Kelimeler: Benzotiyazol, Triazol, Antimikrobiyal aktivite. 
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1. INTRODUCTION 
 
During  the  past  decades,  the  problem  of 
multidrug resistant microorganisms has reached 
on alarming level around the world. Due to this 
reason, novel classes of antibacterial agents with 
new  mechanisms  are  crucial  need  to  combat 
with  the  multidrug-resistant  infections.  In  the 
past years, some azole derivatives were devel-
oped as novel antimicrobial agents, for example, 
Linezolid and Eperezolid are currently used for 
the  treatment  of  multidrug-resistant  Gram-
positive infections (Bayrak et al. 2009). 
 
The  chemistry  of  1,2,4-triazoles  has  re-
ceived  noteworthy  attention  because  of  their 
synthetic  and  biological  significance.  Deriva-
tives of 1,2,4-triazole have been found to have 
difference pharmacological activity, for example 
fungicidal,  bactericidal,  anti-tumor,  anti-
inflammatory,  insecticidal,  and  herbicidal, 
among  others  (Swamy  et  al.  2006).  A  large 
number  of  1,2,4-triazole-containing  ring  sys-
tems,  for  instance  Fluconazole,  Itraconazole, 
Voriconazole,  Ravuconazole  and  Posaconazole 
have  been  incorporated  into  a  wide  variety  of 
therapeutically interesting drug candidates with, 
for example, anti-inflammatory, CNS-stimulant, 
sedative, antianxiety, antimicrobial, and antimy-
cotic activity (Shaker 2006). Furthermore, there 
are  known  drugs  containing  the  1,2,4-triazole 
group (Saadeh et al. 2010), including triazolam, 
alprazolam,  and  etizolam.  In  addition,  thione-
substituted  1,2,4-triazoles  and  their  derivatives 
(Shaker 2006; Saadeh et al. 2010)  have been 
found to have a variety of biological activity, for 
instance antibacterial, antifungal, antitubercular, 
antimycobacterial, anticancer, diuretic, and hy-
poglycemic properties. 
 
Similarly,  benzothiazoles  are  an  important 
class of privileged structures of  medicinal im-
portance  owing  to  their  recognized  biological 
and  therapeutic  activities  (Bose  and  Idrees 
2010).  As  such,  these  heterocycles  constitute 
key structural motifs that show a wide range of 
biological properties, such as imaging agents for 
β-amyloid plaques (Henriksen et al. 2007), in-
hibitors of stearoyl-coenzyme A δ-9 desaturase 
(Black et al. 2006), antitumor (Hutchinson et al. 
2001), antimicrobial (Palmer et al. 1971) agents, 
and  Gram-positive  selective  antibacterials  (Ali 
et al. 2001). After extensive literature search, it 
was observed that, till date enough effort has not 
been  made  to  combine  this  two  moieties  as  a 
single molecular scaffold and to identify novel 
candidates that may be value in designing new 
antimicrobial agent. In view of this data, we re-
ported  the  synthesis  of  new  1,2,4-triazoles  in-
corporated with benzothiazole which possessed 
wide variety of biological activity encouraging 
antimicrobial activity. 
 
2. EXPERIMENTAL 
 
2.1 Chemistry 
 
All chemicals were obtained from Aldrich 
Chemical Co. (Steinheim, Germany). All melt-
ing points (m.p.) were determined in open capil-
laries  on  a  Gallenkamp  apparatus  (Weiss-
Gallenkamp,  Loughborough-United  Kingdom) 
and  are  uncorrected.  The  purity  of  the  com-
pounds  was  routinely  checked  by  thin  layer 
chromatography  (TLC)  using  silica  gel  60G 
(Merck, Darmstadt-Germany). Elemental analy-
ses were performed on a Perkin Elmer EAL 240 
elemental analyser. Spectroscopic data were re-
corded  with  the  following  instruments: 
1H-
NMR: Bruker 400 MHz spectrometer and 
13C-
NMR  Bruker  100  MHz  spectrometer  (Bruker, 
Billerica,  Massachusetts,  USA)  in  DMSO-d6 
using TMS as internal standard; and MS-FAB: 
VG Quattro Mass spectrometer (Agilent, Min-
nesota, USA). 
 
2.1.1 General Procedure for Synthesis of 
the Compounds 
 
N-(benzothiazol-2-yl)-2-chloroacetamides 
(1a-e) 
 
Chloroacetyl chloride (0,1 mol) was added 
dropwise  with  stirring  to  a  mixture  of  2-
aminobenzothiazole/6-substituted-2-
aminobenzothiazole (0,1 mol) and triethylamine 
in toluene at 0-5 °C. The solvent was evaporated 
under  reduced  pressure.    The  residue  was 
washed with water to remove triethylamine hy-
drochloride and crystallized from ethanol (Bhar-
gava and Ram 1965). 
 
N-(Benzothiazol-2-yl)-2-(4H-[1,2,4]triazol-
3-ylsulfanyl) acetamides (3a-j) 
 
A  mixture  of  N-(benzothiazol-2-yl)-2-
chloroacetamides (1a-e) (0.015 mol), appropri-
ate  4H-[1,2,4]triazol-2-thione  (2a-b)  (0.015 
mol) and K2CO3 (0.015 mol) in acetone (50 mL) 
was refluxed for 10-12 h. After cooling to r.t., 
the  solution  was  evaporated  to  dryness.  The 
residue was  washed  with water (200 mL) and 
recrystallized  from  ethanol  (Scheme  1).  Some 
characteristics of the synthesized compounds are 
shown in Table 1. 
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Scheme 1. Synthetic pathway for the preparation of compounds 3a-j. 
 
Table 1. Some characteristics of the compounds 3a-j 
 
Comp.  R  R1  Molecular Formula  M.W. M.P. (
oC)  Yield (%) 
3a  H  H  C11H9N5OS2  291  143-146  68 
3b  Cl  H  C11H8ClN5OS2  325  118-120  72 
3c  CH3 H   C 12H11N5OS2  305  170-172  64 
3d  OCH3 H   C 12H11N5O2S2  321  188-190  63 
3e  OC2H5 H   C 13H13N5O2S2  335  156-158  66 
3f  H  CH3 C 12H11N5OS2  305  229-230  62 
3g  Cl  CH3 C 12H10ClN5OS2  339  259-261  69 
3h  CH3 C H 3 C 13H13N5OS2  319  240-242  65 
3i  OCH3 C H 3 C 13H13N5O2S2  335  223-225  60 
3j  OC2H5 C H 3 C 14H15N5O2S2  349  220-221  67 
 
3a:  IR  [ν,  cm
-1,  KBr]:  3353  (amine  N-H 
stretching), 3216 (amide N-H stretching), 3056 
(aromatic C-H stretching), 2924 (aliphatic C-H 
asymmetric  stretching),  2847  (aliphatic  C-H 
symmetric  stretching),  1684  (amide  C=O 
stretching),  1598,  1552,  1444  (C=N  and  C=C 
stretching),  1330,  1261,  1172,  1015  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ 
4.22 (2H, s, S-CH2), 5.87 (1H, s, triazole N-H), 
7.29 (1H, t, J = 7.7 Hz, benzothiazole H6), 7.43 
(1H, t, J = 7.7 Hz, benzothiazole H5), 7.74 (1H, 
d, J = 8.0 Hz, benzothiazole H7), 7.94 (1H, d, J 
= 8.0 Hz, benzothiazole H4), 8.55 (1H, s, tria-
zole H5), 12.61 (1H, m, N-H). 
13C NMR (100 
MHz, DMSO-d6): δ 34.67 (CH2), 120.53 (CH), 
121.58 (CH), 123.46 (CH), 125.87 (C), 131.49 
(C),  146.35  (CH),  148.54  (C),  150.41  (C), 
156.69 (C), 167.50 (C). MS-FAB
+: m/z: 292 [M 
+ 1]. Anal. Calcd for C11H9N5OS2: C, 45.35; H, 
3.11;  N,  24.04.  Found:  C,  45.33;  H,  3.13;  N, 
24.05. 
 
3b:  IR  [ν,  cm
-1,  KBr]:  3334  (amine  N-H 
stretching), 3194 (amide N-H stretching), 3065 
(aromatic C-H stretching), 2922 (aliphatic C-H 
asymmetric  stretching),  2850  (aliphatic  C-H 
symmetric  stretching),  1684  (amide  C=O 
stretching),  1605,  1554,  1440  (C=N  and  C=C Anadolu Üniversitesi Bilim ve Teknoloji Dergisi - C 1 (2)
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stretching),  1335,  1256,  1173,  1089  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ  
4.26 (2H, s, S-CH2), 5.94 (1H, s, triazole N-H), 
7.45 (1H, d, J = 8.0 Hz, benzothiazole H5), 7.75 
(1H, d, J = 8.0 Hz, benzothiazole H7), 8.11 (1H, 
s, benzothiazole H4), 8.52 (1H, s, triazole H 5), 
12.85  (1H,  m,  N-H). 
13C  NMR  (100  MHz, 
DMSO-d6): δ 34.58 (CH2), 121.39 (CH), 121.73 
(CH),  126.48  (CH),  127.69  (C),  130.93  (C), 
147.41  (CH),  150.46  (C),  155.98  (C),  158.73 
(C), 167.89 (C). MS-FAB
+: m/z: 324 [M-1], 326 
[M  +  1],  327  [M  +  2].  Anal.  Calcd  for 
C11H8ClN5OS2:  C,  40.55;  H,  2.48;  N,  21.50. 
Found: C, 40.47; H, 2.54; N, 21.49. 
 
3c:  IR  [ν,  cm
-1,  KBr]:  3346  (amine  N-H 
stretching), 3191 (amide N-H stretching), 3064 
(aromatic C-H stretching), 2926 (aliphatic C-H 
asymmetric  stretching),  2857  (aliphatic  C-H 
symmetric  stretching),  1675  (amide  C=O 
stretching),  1608,  1565,  1458  (C=N  and  C=C 
stretching),  1335,  1255,  1175,  1055  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ 
2.40  (3H,  s,  CH3),  4.25  (2H,  s,  S-CH2),  5.93 
(1H, s, triazole N-H), 7.26 (1H, d, J = 8.3 Hz, 
benzothiazole H5), 7.65 (1H, d, J = 8.3 Hz, ben-
zothiazole H7), 7.75 (1H, s, benzothiazole H4), 
8.53 (1H, s, triazole H5), 12.60 (1H, m, N-H). 
13C  NMR  (100  MHz,  DMSO-d6):  δ  20.95 
(CH3), 34.56 (CH2), 120.24 (CH), 121.27 (CH), 
127.46  (CH),  130.95  (C),  131.59  (C),  146.47 
(CH),  150.67  (C),  155.95  (C),  156.85  (C), 
167.45 (C). MS-FAB
+: m/z: 306 [M + 1]. Anal. 
Calcd for C12H11N5OS2: C, 47.20; H, 3.63; N, 
22.93. Found: C, 47.28; H, 3.61; N, 22.97. 
 
3d:  IR  [ν,  cm
-1,  KBr]:  3355  (amine  N-H 
stretching), 3189 (amide N-H stretching), 3083 
(aromatic C-H stretching), 2930 (aliphatic C-H 
asymmetric  stretching),  2859  (aliphatic  C-H 
symmetric  stretching),  1676  (amide  C=O 
stretching),  1605,  1582,  1462  (C=N  and  C=C 
stretching),  1334,  1257,  1148,  1061  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ 
3.80 (3H, s, OCH3), 4.20 (2H, s, S-CH2), 5.94 
(1H, s, triazole N-H), 7.03 (1H, dd, J = 8.8, 2.6 
Hz, benzothiazole H5), 7.57 (1H, d, J = 2.6 Hz,  
benzothiazole H7), 7.65 (1H, d, J = 8.8 Hz, ben-
zothiazole H4), 8.49 (1H, m, triazole H5), 13.00 
(1H, m, N-H). 
13C NMR (100 MHz, DMSO-d6): 
δ  34.80  (CH2),  55.52  (CH3),  104.47  (CH), 
115.09 (CH), 121.21 (CH), 132.55 (C), 142.17 
(C),  150.69  (C),  155.80  (CH),  156.14  (C), 
156.61 (C), 167.53 (C). MS-FAB
+: m/z: 322 [M 
+ 1]. Anal. Calcd for C12H11N5O2S2: C, 44.85; 
H, 3.45; N, 21.79. Found: C, 44.81; H, 3.51; N, 
21.87. 
3e:  IR  [ν,  cm
-1,  KBr]:  3350  (amine  N-H 
stretching), 3182 (amide N-H stretching), 3058 
(aromatic C-H stretching), 2926 (aliphatic C-H 
asymmetric  stretching),  2853  (aliphatic  C-H 
symmetric  stretching),  1683  (amide  C=O 
stretching),  1600,  1584,  1452  (C=N  and  C=C 
stretching),  1335,  1220,  1158,  1045  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ 
1.34 (3H, t, J = 7.0 Hz, benzothiazole O-CH 2-
CH3), 4.05 (2H, t, J = 7.0 Hz, benzothiazole O-
CH2-CH3), 4.18 (2H, s, S-CH2), 5.95 (1H, s, tri-
azole N-H), 7.01 (1H, dd, J = 8.8, 2.6 Hz, ben-
zothiazole H5), 7.53 (1H, d, J = 2.6 Hz,  ben-
zothiazole  H7),  7.63  (1H,  d,  J = 8 . 8  H z ,  b e n -
zothiazole H4), 8.46 (1H, s, triazole H5), 12.63 
(1H, m, N-H). 
13C NMR (100 MHz, DMSO-d6): 
δ  14.43  (CH3),  34.84  (CH2),  63.69  (CH2), 
105.08 (CH), 115.41 (CH), 121.18 (CH), 132.53 
(C),  142.08  (C),  145.88  (CH),  155.34  (C), 
155.81 (C), 156.67 (C), 167.55 (C). MS-FAB
+: 
m/z:  336  [M  +  1].  Anal.  Calcd  for 
C13H13N5O2S2:  C,  46.55;  H,  3.91;  N,  20.88. 
Found: C, 46.64; H, 3.93; N, 20.87. 
 
3f:  IR  [ν,  cm
-1,  KBr]:  3350  (amine  N-H 
stretching), 3213 (amide N-H stretching), 3054 
(aromatic C-H stretching), 2925 (aliphatic C-H 
asymmetric  stretching),  2842  (aliphatic  C-H 
symmetric  stretching),  1683  (amide  C=O 
stretching),  1602,  1555,  1447  (C=N  and  C=C 
stretching),  1334,  1264,  1174,  1017  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ 
3.61  (3H,  s,  CH3),  4.22  (2H,  s,  S-CH2),  7.32 
(1H, t, J = 7.2 Hz, benzothiazole H6), 7.45 (1H, 
t, J = 7.2 Hz, benzothiazole H5), 7.77 (1H, d, J = 
8.0 Hz, benzothiazole H7), 7.98 (1H, d, J = 8.0 
Hz, benzothiazole H4), 8.58 (1H, s, triazole H5), 
12.67  (1H,  bs,  N-H). 
13C  NMR  (100  MHz, 
DMSO-d6): δ 30.80 (CH2), 36.37 (CH2), 120.63 
(CH), 121.73 (CH), 123.66 (CH), 126.17 (CH), 
131.41  (C),  146.35  (CH),  148.33  (C),  148.45 
(C),  157.64  (C),  167.24  (C).  MS-FAB
+:  m/z: 
306 [M + 1]. Anal. Calcd for C12H11N5OS2: C, 
47.20; H, 3.63; N, 22.93. Found: C, 47.36; H, 
3.53; N, 22.92. 
 
3g:  IR  [ν,  cm
-1,  KBr]:  3343  (amine  N-H 
stretching), 3200 (amide N-H stretching), 3058 
(aromatic C-H stretching), 2920 (aliphatic C-H 
asymmetric  stretching),  2848  (aliphatic  C-H 
symmetric  stretching),  1683  (amide  C=O 
stretching),  1604,  1557,  1443  (C=N  and  C=C 
stretching),  1336,  1262,  1172,  1087  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ 
3.61  (3H,  s,  CH3),  4.22  (2H,  s,  S-CH2),  7.47 
(1H, d, J = 8.6 Hz, benzothiazole H5), 7.75 (1H, 
d, J = 8.6 Hz, benzothiazole H7), 8.13 (1H, bs, 
benzothiazole  H4) ,  8 . 5 7  ( 1 H ,  s ,  t r i a z o l e  H 5), Anadolu University Journal of Science and Technology - C 1 (2)
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12.76  (1H,  m,  N-H). 
13C  NMR  (100  MHz, 
DMSO-d6): δ 30.79 (CH3), 36.30 (CH2), 121.46 
(CH),  121.85  (CH),  126.53  (CH),  127.70  (C), 
133.12  (C),  146.35  (CH),  147.36  (C),  148.31 
(C),  158.53  (C),  167.49  (C).  MS-FAB
+:  m/z: 
338  [M-1],  340  [M  +  1],  341  [M  +  2].  Anal. 
Calcd for C12H10ClN5OS2: C, 42.41; H, 2.97; N, 
20.61. Found: C, 42.37; H, 2.91; N, 20.59. 
 
3h:  IR  [ν,  cm
-1,  KBr]:  3339  (amine  N-H 
stretching), 3187 (amide N-H stretching), 3064 
(aromatic C-H stretching), 2922 (aliphatic C-H 
asymmetric  stretching),  2851  (aliphatic  C-H 
symmetric  stretching),  1684  (amide  C=O 
stretching),  1608,  1565,  1462  (C=N  and  C=C 
stretching),  1331,  1262,  1170,  1027  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ 
2.41  (3H,  s,  benzothiazole  CH3),  3.61  (3H,  s, 
CH3), 4.20 (2H, s, S-CH2), 7.25 (1H, d, J = 8.3 
Hz, benzothiazole H5), 7.64 (1H, d, J = 8.3 Hz, 
benzothiazole H7), 7.76 (1H, bs, benzothiazole 
H4), 8.58 (1H, s, triazole H5), 12.58 (1H, m, N-
H). 
13C NMR (100 MHz, DMSO-d6): δ 20.95 
(CH3), 30.79 (CH3), 36.34 (CH2), 120.28 (CH), 
121.31 (CH), 127.49 (CH), 131.55 (C), 133.15 
(C),  146.34  (CH),  146.44  (C),  148.34  (C), 
156.73 (C), 167.06 (C). MS-FAB
+: m/z: 320 [M 
+ 1]. Anal. Calcd for C13H13N5OS2: C, 48.89; H, 
4.10;  N,  21.93.  Found:  C,  48.66;  H,  3.93;  N, 
22.02. 
 
3i:  IR  [ν,  cm
-1,  KBr]:  3319  (amine  N-H 
stretching), 3194 (amide N-H stretching), 3068 
(aromatic C-H stretching), 2920 (aliphatic C-H 
asymmetric  stretching),  2849  (aliphatic  C-H 
symmetric  stretching),  1682  (amide  C=O 
stretching),  1610,  1563,  1463  (C=N  and  C=C 
stretching),  1333,  1258,  1167,  1057  (C-N 
stretching). 
1H NMR (400 MHz, DMSO-d6): δ 
3.60  (3H,  s,  CH3),  3.81  (3H,  s,  benzothiazole 
OCH3), 4.21 (2H, s, S-CH2), 7.05 (1H, d, J = 8.6 
Hz, benzothiazole H5), 7.55 (1H, s, benzothia-
zole H7), 7.66 (1H, d, J = 8.6 Hz, benzothiazole 
H4), 8.46 (1H, s, triazole H5), 12.43 (1H, m, N-
H). 
13C NMR (100 MHz, DMSO-d6): δ 20.96 
(CH3), 34.56 (CH2), 55.59 (CH3), 104.28 (CH), 
114.38 (CH), 121.59 (CH), 132.72 (C), 142.57 
(C),  150.34  (CH),  155.63  (C),  156.17  (C), 
156.61 (C), 167.16 (C). MS-FAB
+: m/z: 336 [M 
+ 1]. Anal. Calcd for C13H13N5O2S2: C, 46.55; 
H, 3.91; N, 20.88. Found: C, 46.68; H, 3.96; N, 
20.89. 
 
3j:  IR  [ν,  cm
-1,  KBr]:  3316  (amine  N-H 
stretching), 3220 (amide N-H stretching), 3078 
(aromatic C-H stretching), 2924 (aliphatic C-H 
asymmetric  stretching),  2852  (aliphatic  C-H 
symmetric  stretching),  1675  (amide  C=O 
stretching),  1601,  1580,  1460  (C=N  and  C=C 
stretching), 1260, 1148, 1055 (C-N stretching). 
1H NMR (400 MHz, DMSO-d6): δ 1.36 (3H, t, J 
= 6.7 Hz, benzothiazole O-CH2-CH3), 3.60 (3H, 
s, CH3), 4.07 (2H, q, J = 6.7 Hz, benzothiazole 
O-CH2-CH3), 4.21 (2H, s, S-CH2), 7.03 (1H, d, J 
= 8.8, 2.4 Hz, benzothiazole H5), 7.52 (1H, d, J 
= 2.4 Hz,  benzothiazole H7), 7.62 (1H, d, J = 
8.8 Hz, benzothiazole H4), 8.47 (1H, s, triazole 
H5), 12.55 (1H, m, N-H). 
13C NMR (100 MHz, 
DMSO-d6): δ 14.66 (CH3), 21.00 (CH3), 33.36 
(CH2), 63.62 (CH2), 105.38 (CH), 115.58 (CH), 
121.29  (CH),  132.82  (C),  142.52  (C),  150.39 
(CH),  155.83  (C),  155.97  (C),  156.64  (C), 
167.26 (C). MS-FAB
+: m/z: 350 [M + 1]. Anal. 
Calcd for C14H15N5O2S2: C, 48.12; H, 4.33; N, 
20.04. Found: C, 48.35; H, 4.31; N, 20.07. 
 
2.2 Microbiology 
 
The study was designed to compare MICs 
obtained  by  the  CLSI  reference  M7-A7  broth 
microdilution  method  (Koneman  et  al.  1997; 
NCCLS  2002).  MIC  readings  were  performed 
twice for each chemical agent. For both the anti-
bacterial  and  antifungal  assays  the  compounds 
were dissolved in DMSO. Further dilutions of 
the compounds and standard drugs in test me-
dium were prepared at the required quantities of 
800, 400, 200, 100, 50, 25, 12.5, 6.25, 3.125 and 
1.5625  µg/mL  concentrations  with  Mueller-
Hinton broth and Sabouroud dextrose broth. In 
order to ensure that the solvent per se had no 
effect on bacteria or yeast growth, a control test 
was also performed containing inoculated broth 
supplemented with only DMSO at the same di-
lutions used in our experiments and found inac-
tive  in  culture  medium.  The  observed  data  on 
the  antibacterial  and  antifungal  activity  of  the 
compounds, the control drugs and the test mi-
croorganisms are given in Table-2. 
 
RESULTS AND DISCUSSION 
 
At  first,  2-chloro-N-(benzothiazol-2-
yl)acetamides were synthesized via nucleophilic 
acyl  substitution  reaction  of  2-
aminobenzothiazoles with chloroacetyl chloride 
in the presence of triethylamine (Bhargava and 
Ram 1965). The compounds as starting materi-
als which have triazoline-3-thione structure (2a-
b)  were  obtained  from  Aldrich  Chemical  Co. 
The desired compounds (3a-j) were prepared by 
reacting  2-chloro-N-(benzothiazol-2-
yl)acetamides  with  appropriate  triazoline-3-
thiones (2a-b) under basic conditions. 
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Table 2. Antimicrobial Activities of the compounds 3a-j (mg/mL) 
 
 A   B   C   D   E   F   G   H  
3a  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3b  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3c  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3d  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3e  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3f  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3g  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3h  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3i  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
3j  1.25  1.25  1.25  1.25  1.25  1.25  1.25  1.25 
Reference-1  0.0312  0.0312  0.5  0.0312  0.0156  0.0312  -  - 
Reference-2  -  -  -  -  -  -  0.125  0.25 
 
Reference-1: Chloramphenicole,   Reference -2: Ketoconazole 
 
A: Escherichia coli (NRRL B-3008), B: Staphylococcus aureus (ATCC 6538), C: Pseudomonas aeruginosa 
(ATCC 27853), D: Proteus vulgaris (NRRL B-123), E: Salmonella typhimurium (ATCC 13311), F: Methicillin-
resistant Staphylococcus aureus (MRSA) (clinic isolate) G: Candida albicans (NRRL Y-12983) H: Candida 
parapsilosis (NRRL Y-12696) 
 
The presence of a base favours the thiol form, 
which is prone to nucleophilic substitution reac-
tions.  These  reactions  are  abbreviated  in 
Scheme. 
 
The  compounds  which  have  triazoline-3-
thione  structure  (2a-b)  may  exist  in  two 
tautomeric forms, namely thione form and thiol 
form  (Blackman  and  Polya  1970).  In  the  IR 
spectra, the absence of a band at 2600-2550 cm
-1 
due to the S-H stretching vibration confirms that 
the thione form predominates over the thiol form 
in the solid state. 
 
Acetamide derivatives (3a-j) have a strong, 
characteristic band in the region 1700-1650 cm
-1 
owing  to  the  C=O  stretching  vibration.  The 
asymmetric and symmetric stretching bands for 
aliphatic  C-H  group  appear  at  2925-2920  cm
-1 
and 2850-2845 cm
-1 respectively. The aromatic 
C-H stretching vibration of the compounds (3a-
j) gives rise to a band at 3100-3000 cm
-1. 
 
In the 
1H-NMR spectra of the compounds 
which have triazoline-3-thione structure  (2a-b), 
the signals owing to the NH protons, which are 
showed at 12-13 ppm, are considered as a evi-
dence of the prevalence of the thione form over 
the  thiol  form.  In  the 
1H-NMR  spectra  of 
acetamide  derivatives  (3a-j),  the  signal  due  to 
the amide proton appears at 12-13 ppm. In their 
13C-NMR spectra (3a-j), the signal owing to the 
amide carbon is observed at 167-168 ppm. The 
mass  spectra  of  compounds  showed  [M+1] 
peaks,  in  agreement  with  their  molecular  for-
mula. 
 
MIC’s were recorded as the minimum con-
centration  of  compound,  which  inhibits  the 
growth  of  tested  microorganisms.  The  results 
indicated that all of the tested compounds were 
inactive against the test organism. 
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